Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
16 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
18 Apr 24
8-K
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
29 Feb 24
8-K
Sana Biotechnology Announces Pricing of Upsized Public Offering
8 Feb 24
8-K
Results of Operations and Financial Condition
7 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Regulation FD Disclosure
11 Dec 23
8-K
Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates
8 Nov 23
8-K
Cost Associated with Exit or Disposal Activities
10 Oct 23
8-K
Regulation FD Disclosure
13 Sep 23
8-K
Termination of a Material Definitive Agreement
21 Aug 23
Registration and prospectus
S-3ASR
Automatic shelf registration
1 Mar 24
424B5
Prospectus supplement for primary offering
8 Feb 24
FWP
Free writing prospectus
7 Feb 24
424B5
Prospectus supplement for primary offering
7 Feb 24
S-8
Registration of securities for employees
8 May 23
POS EX
Additional exhibits for listing
1 May 23
POS AM
Prospectus update (post-effective amendment)
16 Mar 23
POSASR
Automatic shelf registration (post-effective amendment)
15 Mar 23
S-3ASR
Automatic shelf registration
4 Aug 22
S-8
Registration of securities for employees
10 May 22
Other
EFFECT
Notice of effectiveness
2 May 23
EFFECT
Notice of effectiveness
4 Feb 21
CERT
Certification of approval for exchange listing
3 Feb 21
CORRESP
Correspondence with SEC
1 Feb 21
CORRESP
Correspondence with SEC
28 Jan 21
UPLOAD
Letter from SEC
25 Jan 21
CORRESP
Correspondence with SEC
20 Jan 21
CORRESP
Correspondence with SEC
12 Jan 21
UPLOAD
Letter from SEC
4 Jan 21
UPLOAD
Letter from SEC
8 Dec 20
Ownership
4
Hans Edgar Bishop
8 Apr 24
3
Initial statement of insider ownership
8 Apr 24
SC 13G/A
FMR LLC
3 Apr 24
4
Patrick Y Yang
11 Mar 24
4
DOUGLAS E WILLIAMS
8 Mar 24
4
Steve Harr
8 Mar 24
4
Christian Hordo
8 Mar 24
4
Nathan Hardy
8 Mar 24
4
Bernard J Cassidy
8 Mar 24
SC 13G/A
BAILLIE GIFFORD & CO
7 Mar 24